21 May 2014 11:45
Instem plc
("Instem" or the "Company")
Result of Annual General Meeting
Instem (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces that at the Annual General Meeting held on Tuesday 20th May, all resolutions were duly passed.
For further information, please contact:
Instem plc | www.instem.com |
Phil Reason, CEO | Tel: +44 (0) 1785 825 600 |
Nigel Goldsmith, CFO |
|
|
|
N+1 Singer (Nominated Adviser & Broker) | Tel: +44 (0) 20 7496 3000 |
Richard Lindley |
|
Nick Owen |
|
|
|
Walbrook PR Ltd | Tel: +44 (0) 20 7933 8780 or instem@walbrookpr.com |
Bob Huxford | Mob: +44 (0)7747 635 908 |
Helen Cresswell | Mob: +44 (0)7841 917 679 |
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutionsfor data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledgethrough the extraction and harmonisation of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com.